New Zealand’s AFT Pharmaceuticals raises funds

19 June 2020 - Deborah Wilkes

Premium

AFT Pharmaceuticals, owner of the Maxigesic combination painkiller, has raised around NZD10 million (USD6.47 million) through issuing new shares. The New Zealand-based company said the move would “increase liquidity and reduce debt”.

Click tags below for more information on topics:

AFT COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: